期刊文献+

血清NTx、BSP和PSA检测在前列腺癌骨转移诊断中的意义 被引量:5

Clinical significance of serum NTx,BSP and PSA in bone metastasis of prostate cancer
原文传递
导出
摘要 目的:探索前列腺癌患者血清中Ⅰ型胶原氨基末端肽(NTx)、骨唾液酸蛋白(BSP)以及前列腺特异抗原(PSA)的含量与骨转移发生之间的关系。方法:收集73例前列腺癌患者的临床资料,其中骨转移组38例,无骨转移组35例。采用酶联免疫吸附法检测两组患者血清中NTx、BSP和PSA的含量并进行统计分析。结果:骨转移组血清中NTx、BSP的含量明显高于无骨转移组,差异有统计学意义(P<0.05);而骨转移组血清PSA含量与无骨转移组比较,差异无统计学意义(P>0.05);血清NTx含量作为骨转移分子标志的灵敏度达90.0%,特异度为68.6%;血清BSP的灵敏度为84.2%,特异度为71.4%;血清PSA的灵敏度和特异度分别为81.6%和37.1%。结论:前列腺癌患者血清中的NTx和BSP含量对骨转移的发生具有重要的预测意义。 Objective: To study the clinical significance of serum pyridinoline cross-linked N-telopeptides of type Ⅰ collagen(NTx),serum bone sialoprotein(BSP) and serum prostate specific antigen(PSA) in diagnosing bone metastasis of prostate cancer.Methods: 73 patients were divided into 2 groups: bone metastasis group(n = 38) and non-bone metastasis group(n = 35).The levels of serum NTx,serum BSP and serum PSA were detected by ELISA.Results: The levels of serum NTx and serum BSP in patients with bone metastasis was significantly higher than in those without bone metastasis(P 0.05),there were no significant differences in serum PSA of the two groups(P 0.05).The sensitivity and specificity of serum NTx in the diagnosis of bone metastasis were 90.0% and 68.6%,respectively;the sensitivity and specificity of serum BSP were 84.2% and 71.4%,respectively;the sensitivity and specificity of serum PSA were 81.6% and 37.1%.Conclusion: The levels of serum NTx and BSP are important biomarkers for the diagnosis of bone metastasis prostate cancer.
出处 《现代医学》 2013年第8期546-549,共4页 Modern Medical Journal
关键词 Ⅰ型胶原氨基末端肽 骨唾液酸蛋白 前列腺特异抗原 骨转移 前列腺癌 N-telopeptides of type Ⅰ collagen bone sialoprotein prostate specific antigen bone metastasis prostate cancer
  • 相关文献

参考文献12

  • 1GARNERO P, BUCHS N, ZEKRI J, et al. Markers of bone turnover for the management of patients with bone metastases from prostate cancer[J]. Br J Cancer,2000,82(4) :858-864.
  • 2DEMERS L M, COSTA L, LIPTON A. Biochemical markers and skeletal metastases [ J ]. Cancer, 2000, 88 ( Suppl 12 ) : S2919 - S2926.
  • 3王薇,王雅杰,傅强.联合检测血清NTx和BSP对乳腺癌和肺癌骨转移的意义[J].中国肿瘤生物治疗杂志,2008,15(5):478-483. 被引量:21
  • 4卢建新,李晓东,张春阳.联合检测血清NTx和BSP对乳腺癌骨转移的意义[J].中国现代普通外科进展,2010,13(12):1005-1006. 被引量:3
  • 5CHUNG J H,PARK M S, KIM Y S, et al. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer [ J ]. Yonsei Med J, 2005,46 ( 3 ) : 388 - 393.
  • 6赵瑞,李鸣.Ⅰ型胶原交联氨基末端肽在前列腺癌骨转移诊断中的意义[J].现代泌尿生殖肿瘤杂志,2010,2(5):234-236. 被引量:2
  • 7JUNG K, LEIN M, STEPHAN C, et al. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread : diagnostic and prognostic implications [ J ]. Int J Cancer, 2004,111 ( 5 ) : 783- 791.
  • 8WALTREGNY D, BELLAHCENE A, LEVAL X, et al. In- creased expression of bone sialoprotein in bone metastases compared with vesveral metastases in human breast and pros- tate cancers [ J ]. J Bone Miner Res,2000,5 ( 5 ) : 834- 843.
  • 9THOMPSON I M,PAULER D K,GOODMAN P J ,et al. Preva- lence of prostate cancer among men with a prostate specific antigen level < or = 4. 0 ng per Milliliter [ J ]. N Engl J Med, 2004,350 (22) :2239-2246.
  • 10刘宁,陈明,陈恕求.P504S/AMACR在前列腺癌患者血清中的表达及其意义[J].现代医学,2010,38(3):266-268. 被引量:6

二级参考文献65

  • 1周桥.前列腺癌Gleason分级[J].中华病理学杂志,2005,34(4):240-243. 被引量:44
  • 2陈文思,陈忠城,梁敏坚.血清PSA在前列腺癌疗效监测中的应用[J].实用医学杂志,2005,21(23):2700-2701. 被引量:2
  • 3戴文斌,宋建达.AMACR/P504S回顾与展望[J].临床泌尿外科杂志,2007,22(3):234-237. 被引量:10
  • 4Demers LM. Bone markers in the management of patients with skeletal metastases [J]. Cancer, 2003,97 ( 3 Suppl) : 874-879.
  • 5Clines GA, Guise TA. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone[ J]. Endoer Relat Cancer, 2005,12 (3):549- 583.
  • 6Detry C, Waltregny D, Quartresooz P, et al. Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix [J]. Calcif Tissue Int, 2003,73( 1 ) :9-14.
  • 7Bellahcene A, Merville MP, Castronovo V. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer[ J]. Cancer Res, 1994,54( 11 ) :2823-2826.
  • 8Zhang JH, Tang J,Wang J, et al. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model[J]. Int J Oncol, 2003,23(4) : 1043-1048.
  • 9Zhang JH, Wang J,Tang J,et al. Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells [J]. Anticancer Res, 2004,24(3a) : 1361-1368.
  • 10Wahregny D, Bellahcene A,de Leval X, et al. Increased expression of bone sialoprotein in bone metastases compared with vesveral metastases in human breast and prostate cancers [ J ]. J Bone Miner Res,2000,15 ( 5 ) : 834-843.

共引文献30

同被引文献56

  • 1樊英,丁晓燕,马飞,袁芃,张频,王佳玉,李青,徐兵河.三阴性乳腺癌首发骨转移患者的临床特征、治疗及预后分析[J].中华临床医师杂志(电子版),2012,6(19):5926-5930. 被引量:4
  • 2赵征,金岩,文玲英.BSP、OPN在小鼠牙胚发育中的表达[J].临床口腔医学杂志,2005,21(12):725-727. 被引量:7
  • 3高志棣,考军,周文丽,范清玲.UNTX水平检测在监测肺癌骨转移中的价值[J].实用癌症杂志,2007,22(2):167-170. 被引量:1
  • 4Tosoian J, Loeb S. PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer [J]. The Scientific World Journal, 2010, 10(1): 1919-1931.
  • 5Murray NP, Calaf GM, Badinez L, et al. P504S expressing circulat- ing prostate cells as a marker for prostate cancer [J]. Ontology re- ports, 2010, 24(3): 687-692.
  • 6Wuttke M, Miiller S, Nitsche DP, et al. Structural characterization of human recombinant and bone-derived bone sialoprotein. Functional implications for cell attachment and hydroxyapatite binding [J]. J Biol Chem, 2001, 276(39): 36839-36848.
  • 7Woitge HW, Pecherstorfer M, Horn E, et al. Serum bone sialopro- tein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma [J]. Br J Cancer, 2001, 84(3): 344-351.
  • 8Karadag A, Ogbureke KU, Fedarko NS, et al. Bone sialoprotein,ma- trix metalloproteinase 2, and alpha (v) beta3 integrin in osteotropic cancer cell invasion [J]. J Natl Cancer Inst, 2004, 96(12): 956-965.
  • 9Ogata Y. Bone sialoprotein and its transcriptional regulatory mecha- nism [J]. J Periodontal Res, 2008, 43(2): 127-135.
  • 10Li Z, Wang Z, Yang L, et al. Fibroblast growth factor 2 regulates bone sialoprotein gene transcription in human breast cancer cells [J]. J Oral Sei, 2010, 52(1): 125-132.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部